INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

10,132 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$458K
5,026 sh
Jan 14, 2026
Page 202 of 254
← PrevNext →
Jan 16, 2026
traded Jan 14, 2026
+2d
SEC Form 4

Evidence

34
BW
Bawel Zachary WDirector
GABCGERMAN AMERICAN BANCORP, INC.
Open-market purchase
BUY$2,000
49 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

33
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$56K
606 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

30
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$102K
3,489 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

30
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
720 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

30
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
123 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

30
EJ
Ellspermann Susan JDirector
GABCGERMAN AMERICAN BANCORP, INC.
Open-market purchase
BUY$1,000
25 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

30
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$6,140
180 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

56
VW
Versaci Vincent WTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$11K
1,336 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

56
MJ
McNally Kevin JosephTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$5,135
634 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

52
VW
Versaci Vincent WTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$3,016
371 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

50
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$3.91M
11.6K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

48
WJ
Weber Clifford JohnTrustee
GLQClough Global Equity Fund
Open-market purchase
BUY$8,160
1,000 sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

48
NR
Neufeld Leah RCHIEF PEOPLE OFFICER
IMRXImmuneering Corp
Open-market purchase
BUY$11K
2,626 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

47
GO
Gayle OswaldChief Financial Officer
LUCYInnovative Eyewear Inc
Open-market purchase
BUY$1,162
700 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

46
MJ
McNally Kevin JosephTrustee
GLVClough Global Dividend & Income Fund
Open-market purchase
BUY$6,240
1,000 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

44
EW
Eager William WPresident, S&P Global Mobility
SPGIS&P Global Inc.
Open-market purchase
BUY$5,954
11 sh
Sep 10, 2025Jan 15, 2026
traded Sep 10, 2025
+127dSEC Form 4

Evidence

44
KC
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$2.87M
100.0K sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

43
SC
Stokes CameronSee Remarks
LAKELAKELAND INDUSTRIES INC
Open-market purchase
BUY$4,244
450 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

43
GO
Gayle OswaldChief Financial Officer
LUCYInnovative Eyewear Inc
Open-market purchase
BUY$507
300 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

42
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$1.27M
3,780 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

42
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Open-market purchase
BUY$2.64M
7,820 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

42
WJ
Weber Clifford JohnTrustee
GLOClough Global Opportunities Fund
Open-market purchase
BUY$6,000
1,000 sh
Jan 15, 2026Jan 15, 2026
traded Jan 15, 2026
+0dSEC Form 4

Evidence

40
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$8.31M
96.0K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

38
DP
Donohoe Bryan PatrickChief Executive Officer
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$107K
21.8K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

36
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$3,664
745 sh
Jan 2, 2025Jan 15, 2026
traded Jan 2, 2025
+378dSEC Form 4

Evidence

35
FA
Feingold AntonGen. Counsel VP and Secretary
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$37K
7,606 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

35
GM
Gonzales Jeffrey MichaelCFO and Treasurer
ACREAres Commercial Real Estate Corp
Open-market sale
SELL$31K
6,218 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

35
EW
Eager William WPresident, S&P Global Mobility
SPGIS&P Global Inc.
Open-market purchase
BUY$5,964
12 sh
Dec 10, 2025Jan 15, 2026
traded Dec 10, 2025
+36dSEC Form 4

Evidence

34
KC
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$107K
3,822 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

33
AS
Acevedo SylviaDirector
CRDOCredo Technology Group Holding Ltd
Open-market sale
SELL$178K
1,100 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

33
AS
Acevedo SylviaDirector
CRDOCredo Technology Group Holding Ltd
Open-market sale
SELL$172K
1,100 sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

32
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$1,901
685 sh
Apr 1, 2025Jan 15, 2026
traded Apr 1, 2025
+289dSEC Form 4

Evidence

32
TC
Tkach CameronExecutive Vice President, COO
RDNWRideNow Group, Inc.
Open-market sale
SELL$4,820
1,553 sh
Mar 19, 2025Jan 15, 2026
traded Mar 19, 2025
+302dSEC Form 4

Evidence

32
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
12.5K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

31
SS
Sijbrandij SytseDirector, 10% Owner
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$1.59M
44.2K sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

30
SM
Sharma ManishChief Strategy & Services Ofcr
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$336K
1,161 sh
Jan 14, 2026Jan 15, 2026
traded Jan 14, 2026
+1dSEC Form 4

Evidence

30
TB
Tighe BrettChief Financial Officer
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$951K
10.0K sh
Jan 13, 2026Jan 15, 2026
traded Jan 13, 2026
+2dSEC Form 4

Evidence

51
FP
Feinberg PeterDirector
IMRXImmuneering Corp
Open-market purchase
BUY$87K
20.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

49
HD
Hildebrandt John DPresident and COO
PSMTPRICESMART INC
Open-market sale
SELL$1.02M
7,421 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence